Innoviva Inc

INVANASDAQ · USD
21.04USD0.00 (-0.48%)
957

Innoviva Inc (INVA) Implied Volatility Current

INVA implied volatility is 60%. IV Rank is 57%, placing current premiums in the middle of their 52-week range.

Read more

Tracking INVA implied volatility helps you identify when options premiums on Innoviva Inc are historically cheap or expensive, and where the best trades are hiding. Innoviva Inc implied volatility reflects the market's expectation of future price movement: when INVA IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Innoviva Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For INVA, tracking metrics like INVA IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on INVA signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP.

The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where INVA implied volatility sits today versus where it has been. Our scanner ranks Innoviva Inc implied volatility against its historical range, surfaces extremes in INVA IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Innoviva Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
57.14%IV Rank
Moderate

IV is slightly elevated - premiums are richer, leaning toward sellers.

Implied Volatility (30d)59.84%

IV Rank57.14%

Historical Volatility (30d)17.17%

IV - HV+42.67%

As of September 21, 2026

Trade options with IV on your side

Track INVA IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial